The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.
Liu, PY
Tee, AE
Milazzo, G
Hannan, KM
Maag, J
Mondal, S
Atmadibrata, B
Bartonicek, N
Peng, H
Ho, N
Mayoh, C
Ciaccio, R
Sun, Y
Henderson, MJ
Gao, J
Everaert, C
Hulme, AJ
Wong, M
Lan, Q
Cheung, BB
Shi, L
Wang, JY
Simon, T
Fischer, M
Zhang, XD
Marshall, GM
Norris, MD
Haber, M
Vandesompele, J
Li, J
Mestdagh, P
Hannan, RD
Dinger, ME
Perini, G
Liu, T
- Publisher:
- Springer Science and Business Media LLC
- Publication Type:
- Journal Article
- Citation:
- Nature communications, 2019, 10, (1), pp. 5026
- Issue Date:
- 2019-11-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, PY | |
dc.contributor.author | Tee, AE | |
dc.contributor.author | Milazzo, G | |
dc.contributor.author | Hannan, KM | |
dc.contributor.author | Maag, J | |
dc.contributor.author | Mondal, S | |
dc.contributor.author | Atmadibrata, B | |
dc.contributor.author | Bartonicek, N | |
dc.contributor.author | Peng, H | |
dc.contributor.author | Ho, N | |
dc.contributor.author | Mayoh, C | |
dc.contributor.author | Ciaccio, R | |
dc.contributor.author | Sun, Y | |
dc.contributor.author | Henderson, MJ | |
dc.contributor.author | Gao, J | |
dc.contributor.author | Everaert, C | |
dc.contributor.author | Hulme, AJ | |
dc.contributor.author | Wong, M | |
dc.contributor.author | Lan, Q | |
dc.contributor.author | Cheung, BB | |
dc.contributor.author | Shi, L | |
dc.contributor.author | Wang, JY | |
dc.contributor.author | Simon, T | |
dc.contributor.author | Fischer, M | |
dc.contributor.author | Zhang, XD | |
dc.contributor.author | Marshall, GM | |
dc.contributor.author | Norris, MD | |
dc.contributor.author | Haber, M | |
dc.contributor.author | Vandesompele, J | |
dc.contributor.author |
Li, J https://orcid.org/0000-0003-1833-7413 |
|
dc.contributor.author | Mestdagh, P | |
dc.contributor.author | Hannan, RD | |
dc.contributor.author | Dinger, ME | |
dc.contributor.author | Perini, G | |
dc.contributor.author | Liu, T | |
dc.date.accessioned | 2021-04-26T05:06:56Z | |
dc.date.available | 2019-10-09 | |
dc.date.available | 2021-04-26T05:06:56Z | |
dc.date.issued | 2019-11-05 | |
dc.identifier.citation | Nature communications, 2019, 10, (1), pp. 5026 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | http://hdl.handle.net/10453/148380 | |
dc.description.abstract | The majority of patients with neuroblastoma due to MYCN oncogene amplification and consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of RNA sequencing data identify the long noncoding RNA lncNB1 as one of the transcripts most over-expressed in MYCN-amplified, compared with MYCN-non-amplified, human neuroblastoma cells and also the most over-expressed in neuroblastoma compared with all other cancers. lncNB1 binds to the ribosomal protein RPL35 to enhance E2F1 protein synthesis, leading to DEPDC1B gene transcription. The GTPase-activating protein DEPDC1B induces ERK protein phosphorylation and N-Myc protein stabilization. Importantly, lncNB1 knockdown abolishes neuroblastoma cell clonogenic capacity in vitro and leads to neuroblastoma tumor regression in mice, while high levels of lncNB1 and RPL35 in human neuroblastoma tissues predict poor patient prognosis. This study therefore identifies lncNB1 and its binding protein RPL35 as key factors for promoting E2F1 protein synthesis, N-Myc protein stability and N-Myc-driven oncogenesis, and as therapeutic targets. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.relation.ispartof | Nature communications | |
dc.relation.isbasedon | 10.1038/s41467-019-12971-3 | |
dc.rights | This is a post-peer-review, pre-copyedit version of an article published in Nature communications. The final authenticated version is available online at: https://dx.doi.org/10.1038/s41467-019-12971-3. | en_US |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Mice, Inbred BALB C | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mice, Nude | |
dc.subject.mesh | Neuroblastoma | |
dc.subject.mesh | GTPase-Activating Proteins | |
dc.subject.mesh | Ribosomal Proteins | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Protein Biosynthesis | |
dc.subject.mesh | Transcription, Genetic | |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | |
dc.subject.mesh | Up-Regulation | |
dc.subject.mesh | Female | |
dc.subject.mesh | E2F1 Transcription Factor | |
dc.subject.mesh | Protein Stability | |
dc.subject.mesh | RNA, Long Noncoding | |
dc.subject.mesh | Carcinogenesis | |
dc.subject.mesh | N-Myc Proto-Oncogene Protein | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Carcinogenesis | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | E2F1 Transcription Factor | |
dc.subject.mesh | Female | |
dc.subject.mesh | GTPase-Activating Proteins | |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mice, Inbred BALB C | |
dc.subject.mesh | Mice, Nude | |
dc.subject.mesh | N-Myc Proto-Oncogene Protein | |
dc.subject.mesh | Neuroblastoma | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Protein Biosynthesis | |
dc.subject.mesh | Protein Stability | |
dc.subject.mesh | RNA, Long Noncoding | |
dc.subject.mesh | Ribosomal Proteins | |
dc.subject.mesh | Transcription, Genetic | |
dc.subject.mesh | Up-Regulation | |
dc.title | The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. | |
dc.type | Journal Article | |
utslib.citation.volume | 10 | |
utslib.location.activity | England | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Strength - AAI - Advanced Analytics Institute Research Centre | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology/A/DRsch The Data Science Institute | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2021-04-26T05:06:51Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 10 | |
utslib.citation.issue | 1 |
Abstract:
The majority of patients with neuroblastoma due to MYCN oncogene amplification and consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of RNA sequencing data identify the long noncoding RNA lncNB1 as one of the transcripts most over-expressed in MYCN-amplified, compared with MYCN-non-amplified, human neuroblastoma cells and also the most over-expressed in neuroblastoma compared with all other cancers. lncNB1 binds to the ribosomal protein RPL35 to enhance E2F1 protein synthesis, leading to DEPDC1B gene transcription. The GTPase-activating protein DEPDC1B induces ERK protein phosphorylation and N-Myc protein stabilization. Importantly, lncNB1 knockdown abolishes neuroblastoma cell clonogenic capacity in vitro and leads to neuroblastoma tumor regression in mice, while high levels of lncNB1 and RPL35 in human neuroblastoma tissues predict poor patient prognosis. This study therefore identifies lncNB1 and its binding protein RPL35 as key factors for promoting E2F1 protein synthesis, N-Myc protein stability and N-Myc-driven oncogenesis, and as therapeutic targets.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph